Slno News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Slno. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Slno Today - Breaking & Trending Today
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) major shareholder Vivo Opportunity, Llc sold 750,000 shares of the firm’s stock in a transaction on Monday, April 29th. The shares were sold at an average price of $47.80, for a total transaction of $35,850,000.00. Following the completion of the transaction, the insider now directly owns 7,668,093 […] ....
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) CEO Bhatnagar Anish sold 18,980 shares of the firm’s stock in a transaction on Monday, April 1st. The stock was sold at an average price of $41.34, for a total value of $784,633.20. Following the sale, the chief executive officer now owns 152,790 shares in the company, […] ....
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) insider Kristen Yen sold 2,218 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $41.34, for a total transaction of $91,692.12. Following the transaction, the insider now directly owns 23,422 shares in the company, valued at […] ....
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) shares shot up 3.6% during mid-day trading on Tuesday . The stock traded as high as $49.00 and last traded at $49.00. 65,622 shares traded hands during trading, a decline of 74% from the average session volume of 249,337 shares. The stock had previously closed at $47.32. […] ....
Piper Sandler began coverage on shares of Soleno Therapeutics (NASDAQ:SLNO – Free Report) in a research note released on Monday morning, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $93.00 target price on the stock. A number of other equities analysts also recently weighed in on SLNO. Guggenheim reissued a buy rating […] ....